This data is derived from company filings and other reputable sources. It has not been generated by AI. It is intended to help verify and validate the AI analysis here. We believe this data to be accurate but we cannot guarentee that it is error free and it should not be relied upon for financial decisions.
| Name | Novo Nordisk A/S |
| Asset Type | EQUITY |
| Industry | Drug Manufacturers – General |
| Market Capitalization | 317039869952 |
| Pe Ratio | 18.684635 |
| Book Value | 31.206 |
| Dividend Yield | 2.34 |
| Eps | 3.71 |
| Analyst Target Price | 87.373695 |
| Trailing Pe | 18.684635 |
| Forward Pe | 17.03194 |
| Beta | 0.224 |
| Price To Sales Ratio | 1.0458496 |
| Price To Book Ratio | 2.2213678 |
| Share Price | 69.32 |
Annual Financial Statements
Ratios
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
| Revenue Growth Rate | 25.03 | 31.26 | 25.68 | N/A |
| New Income Growth Rate | 20.68 | 50.71 | 16.27 | N/A |
| EBITDA Growth Rate | 19.84 | 49.25 | 17.45 | N/A |
| Free Cash Flow Growth Rate | -0.50 | 9.17 | 34.69 | N/A |
| Total Asset Growth Rate | 48.11 | 30.35 | 24.03 | N/A |
| Equity Growt | 34.65 | 27.64 | 18.01 | N/A |
| Gross Margin | 0.85 | 0.85 | 0.84 | 0.83 |
| Operating Margin | 0.44 | 0.44 | 0.42 | 0.42 |
| EBITDA Margin | 0.47 | 0.49 | 0.43 | 0.46 |
| EBIT Margin | 0.44 | 0.45 | 0.39 | 0.42 |
| Net Profit Margin | 0.35 | 0.36 | 0.31 | 0.34 |
| ROE | 0.70 | 0.79 | 0.67 | 0.68 |
| ROA | 0.22 | 0.27 | 0.23 | 0.25 |
| Effective Tax Rate | 0.21 | 0.20 | 0.20 | 0.19 |
| R&D to Revenue | 0.17 | 0.14 | 0.14 | 0.13 |
| SG&A to Revenue | 0.23 | 0.27 | 0.29 | 0.29 |
| Current Ratio | 0.74 | 0.82 | 0.89 | 0.86 |
| Quick Ratio | 0.40 | 0.47 | 0.52 | 0.52 |
| Cash Ratio | 0.07 | 0.08 | 0.10 | 0.11 |
| Cash to Current Assets | 0.10 | 0.10 | 0.12 | 0.13 |
| Debt to Equity | 0.72 | 0.25 | 0.31 | 0.38 |
| Debt to Assets | 0.22 | 0.09 | 0.11 | 0.14 |
| Interest Coverage | 78.56 | 194.13 | 183.70 | 205.43 |
| Net Debt to EBITDA | 0.59 | 0.06 | 0.11 | 0.18 |
| Liabilities to Equity | 2.25 | 1.95 | 1.89 | 1.75 |
| Equity Multiplier | 3.25 | 2.95 | 2.89 | 2.75 |
| ROIC | 0.43 | 0.66 | 0.53 | 0.51 |
| Receivables Turnover | 4.04 | 3.59 | 3.50 | 3.46 |
| Inventory Turnover | 1.09 | 1.12 | 1.17 | 1.21 |
| Asset Turnover | 0.62 | 0.74 | 0.73 | 0.72 |
| Payables Turnover | 1.54 | 1.40 | 1.83 | 2.67 |
| DSO | 90.43 | 101.79 | 104.29 | 105.36 |
| DIO | 334.89 | 324.65 | 312.91 | 302.72 |
| DPO | 236.49 | 261.32 | 199.99 | 136.85 |
| Working Capital Turnover | -5.13 | -7.74 | -13.88 | -10.11 |
| OCF to Sales | 0.42 | 0.47 | 0.45 | 0.39 |
| FCF to OCF | 0.58 | 0.64 | 0.81 | 0.87 |
| Cash Flow Coverage | 1.18 | 4.03 | 3.06 | 2.06 |
| Dividend Payout | -0.44 | -0.38 | -0.46 | -0.45 |
| CapEx Coverage | -2.36 | -2.80 | -5.35 | -7.45 |
| Quality of Income | 1.20 | 1.30 | 1.42 | 1.15 |
| CapEx to Depreciation | -6.00 | -4.13 | -2.00 | -1.23 |
| Book Value per Share | 32.31 | 23.90 | 18.55 | 15.31 |
| Retention Ratio | 1.44 | 1.38 | 1.46 | 1.45 |
| Goodwill to Assets | 0.04 | 0.01 | 0.02 | 0.02 |
| Inventory to CA | 0.25 | 0.23 | 0.23 | 0.23 |
Income Statement
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | -214.24M | 339.49M | -1.03B | 122.88M |
| Tax Rate For Calcs | 0.21 | 0.20 | 0.20 | 0.19 |
| Normalized EBITDA | 138.42B | 112.94B | 82.04B | 64.75B |
| Total Unusual Items | -1.04B | 1.69B | -5.24B | 640.00M |
| Total Unusual Items Excluding Goodwill | -1.04B | 1.69B | -5.24B | 640.00M |
| Net Income From Continuing Operation Net Minority Interest | 100.99B | 83.68B | 55.52B | 47.76B |
| Reconciled Depreciation | 8.54B | 9.41B | 7.36B | 6.03B |
| Reconciled Cost Of Revenue | 44.52B | 35.77B | 28.45B | 23.66B |
| EBITDA | 137.38B | 114.63B | 76.80B | 65.39B |
| EBIT | 128.83B | 105.22B | 69.44B | 59.37B |
| Net Interest Income | -91.00M | 330.00M | -320.00M | -180.00M |
| Interest Expense | 1.64B | 542.00M | 378.00M | 289.00M |
| Interest Income | 1.84B | 1.07B | 239.00M | 231.00M |
| Normalized Income | 101.81B | 82.33B | 59.74B | 47.24B |
| Net Income From Continuing And Discontinued Operation | 100.99B | 83.68B | 55.52B | 47.76B |
| Total Expenses | 162.06B | 129.69B | 102.14B | 82.16B |
| Total Operating Income As Reported | 128.34B | 102.57B | 74.81B | 58.64B |
| Diluted Average Shares | 4.46B | 4.49B | 4.54B | 4.61B |
| Basic Average Shares | 4.45B | 4.48B | 4.53B | 4.59B |
| Diluted EPS | 22.63 | 18.62 | 12.22 | 10.37 |
| Basic EPS | 22.67 | 18.67 | 12.26 | 10.39 |
| Diluted NI Availto Com Stockholders | 100.99B | 83.68B | 55.52B | 47.76B |
| Net Income Common Stockholders | 100.99B | 83.68B | 55.52B | 47.76B |
| Net Income | 100.99B | 83.68B | 55.52B | 47.76B |
| Net Income Including Noncontrolling Interests | 100.99B | 83.68B | 55.52B | 47.76B |
| Net Income Continuous Operations | 100.99B | 83.68B | 55.52B | 47.76B |
| Tax Provision | 26.20B | 20.99B | 13.54B | 11.32B |
| Pretax Income | 127.19B | 104.67B | 69.06B | 59.08B |
| Other Income Expense | -1.06B | 1.77B | -5.43B | 616.00M |
| Earnings From Equity Interest | -17.00M | 81.00M | -189.00M | -24.00M |
| Gain On Sale Of Security | -1.04B | 1.69B | -5.24B | 640.00M |
| Net Non Operating Interest Income Expense | -91.00M | 330.00M | -320.00M | -180.00M |
| Total Other Finance Cost | 289.00M | 197.00M | 181.00M | 122.00M |
| Interest Expense Non Operating | 1.64B | 542.00M | 378.00M | 289.00M |
| Interest Income Non Operating | 1.84B | 1.07B | 239.00M | 231.00M |
| Operating Income | 128.34B | 102.57B | 74.81B | 58.64B |
| Operating Expense | 117.54B | 93.92B | 73.70B | 58.50B |
| Other Operating Expenses | 2.10B | -119.00M | -1.03B | -332.00M |
| Research And Development | 48.06B | 32.44B | 24.05B | 17.77B |
| Selling General And Administration | 67.38B | 61.60B | 50.68B | 41.06B |
| Selling And Marketing Expense | 62.10B | 56.74B | 46.22B | 37.01B |
| General And Administrative Expense | 5.28B | 4.86B | 4.47B | 4.05B |
| Other Gand A | 5.28B | 4.86B | 4.47B | 4.05B |
| Gross Profit | 245.88B | 196.50B | 148.51B | 117.14B |
| Cost Of Revenue | 44.52B | 35.77B | 28.45B | 23.66B |
| Total Revenue | 290.40B | 232.26B | 176.95B | 140.80B |
| Operating Revenue | 680.56B | 608.64B | 455.69B | 340.18B |
Balance Sheet
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
| Treasury Shares Number | 23.66M | 51.71M | 60.20M | 62.20M |
| Ordinary Shares Number | 4.44B | 4.46B | 4.50B | 4.62B |
| Share Issued | 4.46B | 4.51B | 4.56B | 4.68B |
| Net Debt | 80.37B | 6.89B | 8.60B | 11.80B |
| Total Debt | 102.79B | 27.01B | 25.78B | 26.64B |
| Tangible Book Value | 32.40B | 46.16B | 32.55B | 27.57B |
| Invested Capital | 239.51B | 127.84B | 104.74B | 93.26B |
| Working Capital | -56.63B | -30.01B | -12.75B | -13.92B |
| Net Tangible Assets | 32.40B | 46.16B | 32.55B | 27.57B |
| Capital Lease Obligations | 6.77B | 5.73B | 4.53B | 4.13B |
| Common Stock Equity | 143.49B | 106.56B | 83.49B | 70.75B |
| Total Capitalization | 227.73B | 122.54B | 104.26B | 80.40B |
| Total Equity Gross Minority Interest | 143.49B | 106.56B | 83.49B | 70.75B |
| Stockholders Equity | 143.49B | 106.56B | 83.49B | 70.75B |
| Gains Losses Not Affecting Retained Earnings | -1.41B | 1.28B | 2.45B | -1.71B |
| Other Equity Adjustments | -1.41B | 1.28B | 2.45B | -1.71B |
| Treasury Stock | 2.00M | 5.00M | 6.00M | 6.00M |
| Retained Earnings | 144.45B | 104.84B | 80.59B | 72.00B |
| Capital Stock | 446.00M | 451.00M | 456.00M | 462.00M |
| Common Stock | 446.00M | 451.00M | 456.00M | 462.00M |
| Total Liabilities Net Minority Interest | 322.31B | 207.93B | 157.77B | 123.76B |
| Total Non Current Liabilities Net Minority Interest | 104.78B | 38.27B | 36.83B | 24.25B |
| Other Non Current Liabilities | 23.00M | 189.00M | 100.00M | 360.00M |
| Employee Benefits | 903.00M | 742.00M | 762.00M | 1.28B |
| Non Current Pension And Other Postretirement Benefit Plans | 903.00M | 742.00M | 762.00M | 1.28B |
| Non Current Deferred Liabilities | 5.43B | 10.16B | 7.06B | 5.27B |
| Non Current Deferred Taxes Liabilities | 5.43B | 10.16B | 7.06B | 5.27B |
| Long Term Debt And Capital Lease Obligation | 89.67B | 20.53B | 24.32B | 12.96B |
| Long Term Capital Lease Obligation | 5.43B | 4.55B | 3.54B | 3.31B |
| Long Term Debt | 84.25B | 15.98B | 20.77B | 9.65B |
| Long Term Provisions | 8.76B | 6.65B | 4.59B | 4.37B |
| Current Liabilities | 217.53B | 169.66B | 120.94B | 99.52B |
| Other Current Liabilities | 45.52B | 29.98B | 26.51B | 21.78B |
| Current Debt And Capital Lease Obligation | 13.11B | 6.48B | 1.47B | 13.68B |
| Current Capital Lease Obligation | 1.34B | 1.17B | 986.00M | 822.00M |
| Current Debt | 11.78B | 5.30B | 480.00M | 12.86B |
| Other Current Borrowings | 5.98B | 4.85B | N/A | 12.50B |
| Line Of Credit | 449.00M | 456.00M | 480.00M | 359.00M |
| Commercial Paper | 5.34B | 0.00 | N/A | N/A |
| Current Notes Payable | N/A | N/A | 0.00 | 0.00 |
| Current Provisions | 120.33B | 100.48B | 70.29B | 51.52B |
| Payables And Accrued Expenses | 38.56B | 32.72B | 22.68B | 12.53B |
| Payables | 38.56B | 32.72B | 22.68B | 12.53B |
| Total Tax Payable | 9.72B | 7.12B | 7.09B | 3.66B |
| Accounts Payable | 28.85B | 25.61B | 15.59B | 8.87B |
| Total Assets | 465.80B | 314.49B | 241.26B | 194.51B |
| Total Non Current Assets | 304.90B | 174.84B | 133.06B | 108.91B |
| Non Current Deferred Assets | 24.63B | 20.38B | 13.90B | 8.67B |
| Non Current Deferred Taxes Assets | 24.63B | 20.38B | 13.90B | 8.67B |
| Non Current Accounts Receivable | 4.02B | 1.43B | 206.00M | 267.00M |
| Investments And Advances | 2.68B | 1.66B | 1.34B | 1.44B |
| Investmentin Financial Assets | 2.28B | 1.25B | 1.02B | 916.00M |
| Available For Sale Securities | 2.28B | 1.25B | 1.02B | 916.00M |
| Long Term Equity Investment | 400.00M | 410.00M | 327.00M | 525.00M |
| Investmentsin Associatesat Cost | 400.00M | 410.00M | 327.00M | 525.00M |
| Goodwill And Other Intangible Assets | 111.09B | 60.41B | 50.94B | 43.17B |
| Other Intangible Assets | 91.03B | 55.94B | 46.32B | 38.83B |
| Goodwill | 20.06B | 4.46B | 4.62B | 4.35B |
| Net PPE | 162.49B | 90.96B | 66.67B | 55.36B |
| Accumulated Depreciation | -52.40B | -47.62B | -44.76B | -40.52B |
| Gross PPE | 214.88B | 138.58B | 111.43B | 95.89B |
| Construction In Progress | 79.38B | 39.66B | 22.36B | 11.09B |
| Other Properties | 10.17B | 8.98B | 8.11B | 7.78B |
| Machinery Furniture Equipment | 63.20B | 40.95B | 37.55B | 35.94B |
| Properties | 62.14B | 48.99B | 43.40B | 41.08B |
| Current Assets | 160.90B | 139.65B | 108.19B | 85.59B |
| Hedging Assets Current | 6.33B | 2.34B | 2.73B | 1.69B |
| Inventory | 40.85B | 31.81B | 24.39B | 19.62B |
| Inventories Adjustments Allowances | -3.73B | -2.51B | -1.72B | -2.26B |
| Finished Goods | 8.87B | 7.22B | 6.04B | 5.28B |
| Work In Process | 22.34B | 17.60B | 13.67B | 12.29B |
| Raw Materials | 13.37B | 9.50B | 6.39B | 4.31B |
| Receivables | 87.41B | 75.26B | 57.51B | 46.80B |
| Other Receivables | 12.61B | 8.07B | 6.00B | 5.04B |
| Taxes Receivable | 2.85B | 2.42B | 940.00M | 1.12B |
| Accounts Receivable | 71.95B | 64.77B | 50.56B | 40.64B |
| Allowance For Doubtful Accounts Receivable | -2.13B | -1.79B | -1.52B | -1.43B |
| Gross Accounts Receivable | 74.08B | 66.56B | 52.08B | 42.07B |
| Cash Cash Equivalents And Short Term Investments | 26.31B | 30.23B | 23.57B | 17.48B |
| Other Short Term Investments | 10.65B | 15.84B | 10.92B | 6.76B |
| Cash And Cash Equivalents | 15.65B | 14.39B | 12.65B | 10.72B |
| Cash Financial | 15.65B | 14.39B | 12.65B | 10.72B |
Cash Flow Statement
| 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
| Free Cash Flow | 69.66B | 70.01B | 64.13B | 47.62B |
| Repurchase Of Capital Stock | -20.18B | -29.92B | -24.09B | -19.45B |
| Repayment Of Debt | -6.33B | -1.47B | -13.62B | -6.69B |
| Issuance Of Debt | 79.39B | 0.00 | 11.21B | 22.16B |
| Capital Expenditure | -51.31B | -38.90B | -14.75B | -7.38B |
| End Cash Position | 15.65B | 14.39B | 12.65B | 10.72B |
| Other Cash Adjustment Outside Changein Cash | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 14.39B | 12.65B | 10.72B | 12.23B |
| Effect Of Exchange Rate Changes | 455.00M | -119.00M | -238.00M | 591.00M |
| Changes In Cash | 808.00M | 1.86B | 2.17B | -2.10B |
| Financing Cash Flow | 8.73B | -63.16B | -51.80B | -25.49B |
| Cash Flow From Continuing Financing Activities | 8.73B | -63.16B | -51.80B | -25.49B |
| Cash Dividends Paid | -44.14B | -31.77B | -25.30B | -21.52B |
| Common Stock Dividend Paid | N/A | N/A | N/A | N/A |
| Net Common Stock Issuance | -20.18B | -29.92B | -24.09B | -19.45B |
| Common Stock Payments | -20.18B | -29.92B | -24.09B | -19.45B |
| Net Issuance Payments Of Debt | 73.06B | -1.47B | -2.41B | 15.47B |
| Net Long Term Debt Issuance | 73.06B | -1.47B | -2.41B | 15.47B |
| Long Term Debt Payments | -6.33B | -1.47B | -13.62B | -6.69B |
| Long Term Debt Issuance | 79.39B | 0.00 | 11.21B | 22.16B |
| Investing Cash Flow | -128.90B | -43.89B | -24.92B | -31.61B |
| Cash Flow From Continuing Investing Activities | -128.90B | -43.89B | -24.92B | -31.61B |
| Dividends Received Cfi | N/A | 0.00 | 0.00 | 4.00M |
| Net Investment Purchase And Sale | 4.58B | -5.00B | -3.09B | -5.94B |
| Sale Of Investment | 24.39B | 8.29B | 6.64B | 1.17B |
| Purchase Of Investment | -19.81B | -13.29B | -9.73B | -7.11B |
| Net Business Purchase And Sale | -82.16B | 0.00 | -7.08B | -18.28B |
| Sale Of Business | N/A | N/A | N/A | 0.00 |
| Purchase Of Business | -82.16B | 0.00 | -7.08B | -18.28B |
| Net Intangibles Purchase And Sale | -4.14B | -13.09B | -2.61B | -1.05B |
| Purchase Of Intangibles | -4.14B | -13.09B | -2.61B | -1.05B |
| Net PPE Purchase And Sale | -47.16B | -25.81B | -12.15B | -6.33B |
| Sale Of PPE | N/A | N/A | 0.00 | 0.00 |
| Purchase Of PPE | -47.16B | -25.81B | -12.15B | -6.33B |
| Operating Cash Flow | 120.97B | 108.91B | 78.89B | 55.00B |
| Cash Flow From Continuing Operating Activities | 120.97B | 108.91B | 78.89B | 55.00B |
| Taxes Refund Paid | -29.64B | -25.90B | -14.52B | -14.44B |
| Interest Received Cfo | 1.88B | 1.07B | 276.00M | 241.00M |
| Interest Paid Cfo | -612.00M | -491.00M | -272.00M | -261.00M |
| Change In Working Capital | -11.99B | -13.38B | -5.54B | -9.06B |
| Change In Other Working Capital | 2.51B | -1.24B | 1.16B | 74.00M |
| Change In Other Current Liabilities | 9.12B | 5.19B | 3.75B | 2.60B |
| Change In Payables And Accrued Expense | -280.00M | 7.59B | 5.15B | 3.14B |
| Change In Payable | -280.00M | 7.59B | 5.15B | 3.14B |
| Change In Account Payable | 3.24B | 10.02B | 6.72B | 3.15B |
| Change In Inventory | -9.04B | -7.42B | -4.77B | -1.08B |
| Change In Receivables | -14.31B | -17.50B | -10.82B | -13.79B |
| Changes In Account Receivables | -7.18B | -14.21B | -9.92B | -12.91B |
| Other Non Cash Items | 2.74B | -2.52B | 2.37B | -3.89B |
| Stock Based Compensation | 2.29B | 2.15B | 1.54B | 1.04B |
| Provisionand Write Offof Assets | 21.03B | 32.23B | 18.46B | N/A |
| Asset Impairment Charge | 10.56B | N/A | 809.00M | N/A |
| Deferred Tax | 26.20B | 20.99B | 13.54B | 11.32B |
| Deferred Income Tax | 26.20B | 20.99B | 13.54B | 11.32B |
| Depreciation Amortization Depletion | 8.54B | 9.41B | 7.36B | 6.03B |
| Depreciation And Amortization | 8.54B | 9.41B | 7.36B | 6.03B |
| Amortization Cash Flow | 2.51B | N/A | 1.60B | N/A |
| Amortization Of Intangibles | 2.51B | N/A | 1.60B | N/A |
| Depreciation | 6.03B | 9.41B | 7.36B | 6.03B |
| Operating Gains Losses | -11.03B | 1.65B | 138.00M | 16.27B |
| Pension And Employee Benefit Expense | -119.00M | 13.00M | 615.00M | 16.58B |
| Earnings Losses From Equity Investments | 17.00M | -81.00M | 189.00M | 24.00M |
| Gain Loss On Investment Securities | -5.08B | -556.00M | 2.57B | -340.00M |
| Net Foreign Currency Exchange Gain Loss | -5.85B | 2.28B | -3.24B | N/A |
| Gain Loss On Sale Of Business | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | 100.99B | 83.68B | 55.52B | 47.76B |
Quarterly Financial Statements
Ratios
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| Revenue Growth Rate | -8.87 | 20.15 | 4.78 | 4.15 | N/A |
| New Income Growth Rate | 2.85 | 3.40 | 36.16 | -21.08 | N/A |
| EBITDA Growth Rate | 31.77 | -6.45 | 4.52 | -3.16 | N/A |
| Free Cash Flow Growth Rate | -335.02 | -113.58 | -15.88 | 602.45 | N/A |
| Total Asset Growth Rate | 5.02 | 17.20 | 7.60 | 23.57 | N/A |
| Equity Growt | -3.45 | 19.05 | 7.11 | 13.76 | N/A |
| Gross Margin | 0.83 | 0.85 | 0.84 | 0.85 | 0.85 |
| Operating Margin | 0.50 | 0.43 | 0.47 | 0.38 | 0.49 |
| EBITDA Margin | 0.59 | 0.41 | 0.52 | 0.53 | 0.56 |
| EBIT Margin | 0.54 | 0.41 | 0.49 | 0.40 | 0.52 |
| Net Profit Margin | 0.37 | 0.33 | 0.38 | 0.29 | 0.39 |
| ROE | 0.21 | 0.20 | 0.23 | 0.18 | 0.26 |
| ROA | 0.06 | 0.06 | 0.07 | 0.05 | 0.08 |
| Effective Tax Rate | 0.22 | 0.21 | 0.21 | 0.21 | 0.20 |
| R&D to Revenue | 0.13 | 0.16 | 0.13 | 0.24 | 0.13 |
| SG&A to Revenue | 0.21 | 0.24 | 0.23 | 0.24 | 0.22 |
| Current Ratio | 0.74 | 0.74 | 0.94 | 0.94 | 0.70 |
| Quick Ratio | 0.46 | 0.40 | 0.59 | 0.62 | 0.38 |
| Cash Ratio | 0.16 | 0.07 | 0.27 | 0.28 | 0.04 |
| Cash to Current Assets | 0.22 | 0.10 | 0.29 | 0.30 | 0.05 |
| Debt to Equity | 0.86 | 0.72 | 0.47 | 0.51 | 0.27 |
| Debt to Assets | 0.24 | 0.22 | 0.14 | 0.15 | 0.09 |
| Interest Coverage | 8.15 | -57.00 | 42.88 | 17.22 | 16.39 |
| Net Debt to EBITDA | 1.73 | 2.30 | N/A | 0.12 | 0.56 |
| Liabilities to Equity | 2.53 | 2.25 | 2.30 | 2.28 | 2.02 |
| Equity Multiplier | 3.53 | 3.25 | 3.30 | 3.28 | 3.02 |
| ROIC | 0.13 | 0.12 | 0.16 | 0.13 | 0.22 |
| Receivables Turnover | 1.12 | 1.19 | 1.08 | 1.07 | 1.15 |
| Inventory Turnover | 0.30 | 0.32 | 0.30 | 0.28 | 0.30 |
| Asset Turnover | 0.16 | 0.18 | 0.18 | 0.18 | 0.22 |
| Payables Turnover | 0.66 | 0.45 | 0.47 | 0.35 | 0.76 |
| DSO | 324.67 | 306.49 | 339.35 | 340.89 | 318.36 |
| DIO | 1.2K | 1.1K | 1.2K | 1.3K | 1.2K |
| DPO | 554.32 | 808.41 | 777.22 | 1.1K | 478.74 |
| Working Capital Turnover | -1.27 | -1.51 | -5.40 | -6.54 | -1.33 |
| OCF to Sales | 0.31 | 0.14 | 0.61 | 0.74 | 0.22 |
| FCF to OCF | 0.41 | -0.35 | 0.71 | 0.74 | 0.37 |
| Cash Flow Coverage | 0.21 | 0.12 | 0.77 | 0.89 | 0.53 |
| Dividend Payout | -1.21 | 0.00 | -0.57 | 0.00 | -1.12 |
| CapEx Coverage | -1.69 | -0.74 | -3.51 | -3.82 | -1.59 |
| Quality of Income | 0.85 | 0.44 | 1.61 | 2.52 | 0.56 |
| CapEx to Depreciation | -3.81 | 3.09 | -5.82 | -1.50 | -3.09 |
| Book Value per Share | 31.19 | 32.31 | 27.08 | 25.27 | 22.17 |
| Retention Ratio | 2.21 | 1.00 | 1.57 | 1.00 | 2.12 |
| Goodwill to Assets | N/A | 0.04 | N/A | N/A | N/A |
| Inventory to CA | 0.25 | 0.25 | 0.19 | 0.20 | 0.29 |
Income Statement
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.22 | 0.21 | 0.21 | 0.21 | 0.20 |
| Normalized EBITDA | 46.05B | 34.94B | 37.35B | 35.74B | 36.91B |
| Net Income From Continuing Operation Net Minority Interest | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Reconciled Depreciation | 3.83B | -5.36B | 2.15B | 8.85B | 2.91B |
| Reconciled Cost Of Revenue | 12.89B | 13.02B | 11.31B | 10.27B | 9.92B |
| EBITDA | 46.05B | 34.94B | 37.35B | 35.74B | 36.91B |
| EBIT | 42.22B | 34.94B | 35.20B | 26.89B | 33.99B |
| Net Interest Income | -1.76B | -123.00M | 562.00M | -602.00M | 72.00M |
| Interest Expense | 5.18B | -613.00M | 821.00M | 1.56B | 2.07B |
| Interest Income | 3.42B | -447.00M | 1.38B | 960.00M | 2.15B |
| Normalized Income | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Net Income From Continuing And Discontinued Operation | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Total Expenses | 39.30B | 48.95B | 37.49B | 42.13B | 33.50B |
| Total Operating Income As Reported | 38.79B | 36.74B | 33.82B | 25.93B | 31.85B |
| Diluted Average Shares | 4.45B | N/A | 4.46B | 4.47B | 4.47B |
| Basic Average Shares | 4.44B | N/A | 4.45B | 4.46B | 4.46B |
| Diluted EPS | 6.53 | N/A | 6.12 | 4.49 | 5.68 |
| Basic EPS | 6.54 | N/A | 6.13 | 4.50 | 5.70 |
| Diluted NI Availto Com Stockholders | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Net Income Common Stockholders | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Net Income | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Net Income Including Noncontrolling Interests | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Net Income Continuous Operations | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
| Tax Provision | 8.00B | 7.33B | 7.08B | 5.28B | 6.51B |
| Pretax Income | 37.03B | 35.56B | 34.38B | 25.33B | 31.92B |
| Net Non Operating Interest Income Expense | -1.76B | -123.00M | 562.00M | -602.00M | 72.00M |
| Interest Expense Non Operating | 5.18B | -613.00M | 821.00M | 1.56B | 2.07B |
| Interest Income Non Operating | 3.42B | -447.00M | 1.38B | 960.00M | 2.15B |
| Operating Income | 38.79B | 36.74B | 33.82B | 25.93B | 31.85B |
| Operating Expense | 26.41B | 35.92B | 26.18B | 31.85B | 23.59B |
| Other Operating Expenses | -14.00M | 1.84B | 101.00M | -405.00M | 568.00M |
| Research And Development | 10.31B | 13.80B | 9.49B | 16.17B | 8.61B |
| Selling General And Administration | 16.11B | 20.28B | 16.59B | 16.09B | 14.41B |
| Selling And Marketing Expense | 14.89B | 18.70B | 15.21B | 14.93B | 13.26B |
| General And Administrative Expense | 1.22B | 1.58B | 1.38B | 1.16B | 1.16B |
| Other Gand A | 1.22B | 1.58B | 1.38B | 1.16B | 1.16B |
| Gross Profit | 65.20B | 72.66B | 60.00B | 57.79B | 55.43B |
| Cost Of Revenue | 12.89B | 13.02B | 11.31B | 10.27B | 9.92B |
| Total Revenue | 78.09B | 85.68B | 71.31B | 68.06B | 65.35B |
| Operating Revenue | 78.09B | 475.84B | 71.31B | 68.06B | 65.35B |
Balance Sheet
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| Treasury Shares Number | N/A | 23.66M | 14.00M | 11.43M | 48.09M |
| Ordinary Shares Number | 4.44B | 4.44B | 4.45B | 4.45B | 4.46B |
| Share Issued | 4.44B | 4.46B | 4.46B | 4.46B | 4.51B |
| Net Debt | 79.78B | 80.37B | N/A | 4.24B | 20.60B |
| Total Debt | 118.72B | 102.79B | 56.97B | 57.06B | 26.93B |
| Tangible Book Value | 29.16B | 32.40B | 66.03B | 57.02B | 39.27B |
| Invested Capital | 257.26B | 239.51B | 177.49B | 169.58B | 125.84B |
| Working Capital | -61.72B | -56.63B | -13.20B | -10.41B | -49.19B |
| Net Tangible Assets | 29.16B | 32.40B | 66.03B | 57.02B | 39.27B |
| Capital Lease Obligations | N/A | 6.77B | N/A | N/A | N/A |
| Common Stock Equity | 138.54B | 143.49B | 120.52B | 112.52B | 98.91B |
| Total Capitalization | 234.85B | 227.73B | 171.97B | 164.13B | 115.67B |
| Total Equity Gross Minority Interest | 138.54B | 143.49B | 120.52B | 112.52B | 98.91B |
| Stockholders Equity | 138.54B | 143.49B | 120.52B | 112.52B | 98.91B |
| Gains Losses Not Affecting Retained Earnings | 777.00M | -1.41B | -1.59B | -73.00M | -585.00M |
| Other Equity Adjustments | 777.00M | -1.41B | -1.59B | -73.00M | -585.00M |
| Treasury Stock | 2.00M | 2.00M | 1.00M | 1.00M | 5.00M |
| Retained Earnings | 137.32B | 144.45B | 121.67B | 112.15B | 99.05B |
| Capital Stock | 446.00M | 446.00M | 446.00M | 446.00M | 451.00M |
| Common Stock | 446.00M | 446.00M | 446.00M | 446.00M | 451.00M |
| Total Liabilities Net Minority Interest | 350.62B | 322.31B | 276.92B | 256.86B | 200.01B |
| Total Non Current Liabilities Net Minority Interest | 114.50B | 104.78B | 68.56B | 68.95B | 34.40B |
| Other Non Current Liabilities | 21.00M | 23.00M | 16.00M | 16.00M | 15.00M |
| Employee Benefits | 836.00M | 903.00M | 793.00M | 763.00M | 784.00M |
| Non Current Pension And Other Postretirement Benefit Plans | 836.00M | 903.00M | 793.00M | 763.00M | 784.00M |
| Non Current Deferred Liabilities | 8.71B | 5.43B | 8.65B | 9.04B | 9.66B |
| Non Current Deferred Taxes Liabilities | 8.71B | 5.43B | 8.65B | 9.04B | 9.66B |
| Long Term Debt And Capital Lease Obligation | 96.31B | 89.67B | 51.45B | 51.61B | 16.76B |
| Long Term Capital Lease Obligation | N/A | 5.43B | N/A | N/A | N/A |
| Long Term Debt | 96.31B | 84.25B | 51.45B | 51.61B | 16.76B |
| Long Term Provisions | 8.63B | 8.76B | 7.64B | 7.53B | 7.18B |
| Current Liabilities | 236.12B | 217.53B | 208.36B | 187.91B | 165.61B |
| Other Current Liabilities | 60.98B | 45.52B | 35.12B | 32.30B | 33.53B |
| Current Debt And Capital Lease Obligation | 22.41B | 13.11B | 5.52B | 5.45B | 10.16B |
| Current Capital Lease Obligation | N/A | 1.34B | N/A | N/A | N/A |
| Current Debt | 22.41B | 11.78B | 5.52B | 5.45B | 10.16B |
| Other Current Borrowings | 22.41B | 5.98B | 5.52B | 5.45B | 10.16B |
| Line Of Credit | N/A | 449.00M | N/A | N/A | N/A |
| Commercial Paper | N/A | 5.34B | N/A | N/A | N/A |
| Current Provisions | 117.65B | 120.33B | 128.99B | 114.49B | 102.94B |
| Payables And Accrued Expenses | 35.08B | 38.56B | 38.73B | 35.66B | 18.97B |
| Payables | 35.08B | 38.56B | 38.73B | 35.66B | 18.97B |
| Total Tax Payable | 15.50B | 9.72B | 14.65B | 5.91B | 5.96B |
| Accounts Payable | 19.58B | 28.85B | 24.08B | 29.76B | 13.01B |
| Total Assets | 489.16B | 465.80B | 397.44B | 369.38B | 298.92B |
| Total Non Current Assets | 314.77B | 304.90B | 202.28B | 191.88B | 182.50B |
| Non Current Deferred Assets | 26.27B | 24.63B | 23.46B | 22.57B | 20.97B |
| Non Current Deferred Taxes Assets | 26.27B | 24.63B | 23.46B | 22.57B | 20.97B |
| Non Current Accounts Receivable | 4.04B | 4.02B | 2.46B | 2.18B | 2.01B |
| Investments And Advances | 2.70B | 2.68B | 2.05B | 1.66B | 1.65B |
| Investmentin Financial Assets | 2.31B | 2.28B | 1.64B | 1.25B | 1.24B |
| Available For Sale Securities | 2.31B | 2.28B | 1.64B | 1.25B | 1.24B |
| Long Term Equity Investment | 394.00M | 400.00M | 404.00M | 412.00M | 407.00M |
| Investmentsin Associatesat Cost | 394.00M | 400.00M | 404.00M | 412.00M | 407.00M |
| Goodwill And Other Intangible Assets | 109.38B | 111.09B | 54.49B | 55.50B | 59.64B |
| Other Intangible Assets | N/A | 91.03B | N/A | N/A | N/A |
| Goodwill | N/A | 20.06B | N/A | N/A | N/A |
| Net PPE | 172.38B | 162.49B | 119.83B | 109.98B | 98.23B |
| Accumulated Depreciation | N/A | -52.40B | N/A | N/A | N/A |
| Gross PPE | N/A | 214.88B | N/A | N/A | N/A |
| Construction In Progress | N/A | 79.38B | N/A | N/A | N/A |
| Other Properties | N/A | 10.17B | N/A | N/A | N/A |
| Machinery Furniture Equipment | N/A | 63.20B | N/A | N/A | N/A |
| Properties | N/A | 62.14B | N/A | N/A | N/A |
| Current Assets | 174.40B | 160.90B | 195.16B | 177.50B | 116.42B |
| Hedging Assets Current | 3.63B | 6.33B | 2.71B | 2.36B | 1.77B |
| Inventory | 42.85B | 40.85B | 37.94B | 36.36B | 33.60B |
| Inventories Adjustments Allowances | N/A | -3.73B | N/A | N/A | N/A |
| Finished Goods | N/A | 8.87B | N/A | N/A | N/A |
| Work In Process | N/A | 22.34B | N/A | N/A | N/A |
| Raw Materials | N/A | 13.37B | N/A | N/A | N/A |
| Receivables | 86.37B | 87.41B | 79.63B | 76.13B | 71.75B |
| Other Receivables | 13.92B | 12.61B | 10.13B | 9.67B | 8.64B |
| Taxes Receivable | 2.98B | 2.85B | 3.20B | 2.90B | 6.11B |
| Accounts Receivable | 69.46B | 71.95B | 66.30B | 63.56B | 57.00B |
| Allowance For Doubtful Accounts Receivable | N/A | -2.13B | N/A | N/A | N/A |
| Gross Accounts Receivable | N/A | 74.08B | N/A | N/A | N/A |
| Cash Cash Equivalents And Short Term Investments | 41.55B | 26.31B | 74.88B | 62.65B | 9.30B |
| Other Short Term Investments | 2.61B | 10.65B | 17.86B | 9.83B | 2.98B |
| Cash And Cash Equivalents | 38.94B | 15.65B | 57.02B | 52.82B | 6.32B |
| Cash Financial | 38.94B | 15.65B | 57.02B | 52.82B | 6.32B |
Cash Flow Statement
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | 10.01B | -4.26B | 31.35B | 37.27B | 5.30B |
| Repurchase Of Capital Stock | -1.39B | -7.49B | -2.40B | -7.45B | -2.84B |
| Repayment Of Debt | -12.03B | -433.00M | -532.00M | -5.05B | -317.00M |
| Issuance Of Debt | 27.36B | 44.76B | 119.00M | 34.51B | 0.00 |
| Capital Expenditure | -14.59B | -16.56B | -12.50B | -13.24B | -9.01B |
| End Cash Position | 38.94B | 15.65B | 57.02B | 52.82B | 6.32B |
| Beginning Cash Position | 15.65B | 57.02B | 52.82B | 6.32B | 14.39B |
| Effect Of Exchange Rate Changes | -86.00M | 717.00M | -348.00M | 42.00M | 44.00M |
| Changes In Cash | 23.37B | -42.08B | 4.54B | 46.45B | -8.11B |
| Financing Cash Flow | 5.45B | 36.84B | -18.40B | 16.68B | -26.38B |
| Cash Flow From Continuing Financing Activities | 5.45B | 36.84B | -18.40B | 16.68B | -26.38B |
| Net Other Financing Charges | 26.78B | N/A | N/A | N/A | 5.33B |
| Cash Dividends Paid | -35.27B | 0.00 | -15.58B | 0.00 | -28.56B |
| Net Common Stock Issuance | -1.39B | -7.49B | -2.40B | -7.45B | -2.84B |
| Common Stock Payments | -1.39B | -7.49B | -2.40B | -7.45B | -2.84B |
| Net Issuance Payments Of Debt | 15.33B | 44.33B | -413.00M | 29.46B | -317.00M |
| Net Long Term Debt Issuance | 15.33B | 44.33B | -413.00M | 29.46B | -317.00M |
| Long Term Debt Payments | -12.03B | -433.00M | -532.00M | -5.05B | -317.00M |
| Long Term Debt Issuance | 27.36B | 44.76B | 119.00M | 34.51B | 0.00 |
| Investing Cash Flow | -6.67B | -91.22B | -20.90B | -20.73B | 3.96B |
| Cash Flow From Continuing Investing Activities | -6.67B | -91.22B | -20.90B | -20.73B | 3.96B |
| Net Investment Purchase And Sale | 7.91B | 6.84B | -8.40B | -6.83B | 12.96B |
| Sale Of Investment | 8.03B | 7.19B | 35.00M | 3.04B | 14.12B |
| Purchase Of Investment | -115.00M | -353.00M | -8.44B | -9.87B | -1.16B |
| Net Business Purchase And Sale | N/A | -81.50B | 0.00 | N/A | N/A |
| Purchase Of Business | N/A | -81.50B | 0.00 | N/A | N/A |
| Net Intangibles Purchase And Sale | -1.16B | -457.00M | -385.00M | -2.77B | -535.00M |
| Purchase Of Intangibles | -1.16B | -457.00M | -385.00M | -2.77B | -535.00M |
| Net PPE Purchase And Sale | -13.42B | -16.10B | -12.12B | -10.47B | -8.47B |
| Purchase Of PPE | -13.42B | -16.10B | -12.12B | -10.47B | -8.47B |
| Operating Cash Flow | 24.59B | 12.30B | 43.85B | 50.50B | 14.31B |
| Cash Flow From Continuing Operating Activities | 24.59B | 12.30B | 43.85B | 50.50B | 14.31B |
| Taxes Refund Paid | -2.67B | -12.95B | -615.00M | -3.94B | -12.12B |
| Interest Received Cfo | 694.00M | 813.00M | 524.00M | 67.00M | 480.00M |
| Interest Paid Cfo | -833.00M | -253.00M | -142.00M | -77.00M | -140.00M |
| Change In Working Capital | -16.43B | -981.00M | -11.26B | 9.86B | -9.61B |
| Other Non Cash Items | 2.97B | -27.37B | 18.81B | 10.42B | 874.00M |
| Deferred Tax | 8.00B | 7.33B | 7.08B | 5.28B | 6.51B |
| Deferred Income Tax | 8.00B | 7.33B | 7.08B | 5.28B | 6.51B |
| Depreciation Amortization Depletion | 3.83B | -5.36B | 2.15B | 8.85B | 2.91B |
| Depreciation And Amortization | 3.83B | -5.36B | 2.15B | 8.85B | 2.91B |
| Depreciation | 3.83B | -7.88B | 2.15B | 8.85B | 2.91B |
| Net Income From Continuing Operations | 29.03B | 28.23B | 27.30B | 20.05B | 25.41B |
Legal Disclaimer
The information contained on this website and associated documents, including all text, data, analyses, opinions, and forward-looking statements, is provided solely for general informational purposes and does not constitute financial, investment, legal, or tax advice. The content has been generated by an artificial intelligence tool using publicly available data and company filings. Although every effort has been made to ensure accuracy, the information is provided “as is” without any warranty—express or implied—of completeness, accuracy, reliability, or suitability for any purpose.
Not Regulated Advice
No FCA Authorization: We are not authorized or regulated by the Financial Conduct Authority (FCA) or any other financial regulatory body to offer investment advice or recommendations. Nothing in this report should be construed as a solicitation, recommendation, or endorsement to buy, sell, or hold any security or financial instrument.
Independent Decision-Making: Investors are strongly encouraged to conduct their own research and consult with a licensed financial advisor or other professional before making any financial decisions. Reliance on the information provided herein is solely at your own risk.
Forward-Looking Statements
This report may contain forward-looking statements, which are based on current expectations, assumptions, and projections that involve risks and uncertainties. Actual results may differ materially from those expressed or implied by these statements. We do not undertake any obligation to update or revise any forward-looking statements in light of new information or future developments.
Limitation of Liability
Under no circumstances shall Aipha.io or its affiliates, employees, or agents be liable for any direct, indirect, incidental, consequential, or other damages arising out of or in connection with the use of, or reliance on, the information contained in this report—even if advised of the possibility of such damages. This includes, without limitation, any loss of profit, revenue, or data.
Use at Your Own Risk
By using this report, you acknowledge that you have read and understood this disclaimer and agree that any reliance on the information provided is at your own risk. [Your Company Name/Aipha.io] expressly disclaims any and all liability for any loss or damage of any kind incurred as a result of any use of this report.